Skip to main content

Want a detailed portfolio tracker?

Arcus Biosciences (RCUS) P/E (2018 - 2026)

Arcus Biosciences (RCUS) P/E from Apr 2, 2018 to Jul 20, 2026. The TTM Arcus Biosciences (RCUS) P/E is -6.73. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Arcus Biosciences (RCUS)

YearP/EChange
2026-6.73+18.20%
2025-5.70+18.11%
2024-4.82+0.22%
2023-4.81-127.22%
202217.68-67.25%
202153.99-544.75%
2020-12.14+123.35%
2019-5.43-43.74%
2018-9.66N/A

Comparison Arcus Biosciences (RCUS) P/E with competitors

Arcus Biosciences (RCUS) P/E is -6.73.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.03%
NBYStablecoin Development Corp0.00-100.06%
ENLVEnlivex Ltd0.07-101.11%
FGENFibroGen Inc0.24-103.57%
CHRSCoherus Biosciences Inc0.85-112.60%
FBIOFortress Biotech Inc0.95-114.10%
ORMPOramed Pharmaceuticals Inc1.50-122.32%
AGENAgenus Inc3.01-144.70%
INVAInnoviva Inc3.15-146.84%
VXRTVaxart Inc3.55-152.72%
CRMDCorMedix Inc3.63-153.89%
CVACCureVac N.V.4.45-166.03%
GLPGGalapagos NV4.86-172.16%
SRPTSarepta Therapeutics Inc4.88-172.51%
ABEOAbeona Therapeutics Inc5.39-180.02%
ABUSArbutus Biopharma Corp5.60-183.11%
ZVRAZevra Therapeutics Inc5.89-187.44%
SPROSpero Therapeutics Inc6.23-192.51%
CGENCompugen Ltd6.31-193.78%
RIGLRigel Pharmaceuticals6.87-202.06%
SLXNSilexion Therapeutics Corp7.30-208.36%
OMEROmeros Corporation9.26-237.51%
AUPHAurinia Pharmaceuticals Inc9.58-242.36%
PLXProtalix BioTherapeutics Inc10.89-261.75%
ACADAcadia Pharmaceuticals Inc11.73-274.19%
TBPHTheravance Biopharma Inc12.26-282.12%
ADMAAdma Biologics Inc12.42-284.44%
HRMYHarmony Biosciences Holdings Inc13.82-305.26%
SABSSAB Biotherapeutics Inc14.14-309.95%
NAGENiagen Bioscience Inc14.82-320.08%
INCYIncyte Corp15.82-335.00%
REGNRegeneron Pharmaceuticals Inc15.86-335.51%
PBYIPuma Biotechnology Inc17.32-357.18%
CPRXCatalyst Pharmaceuticals Inc17.44-359.01%
EXELExelixis Inc17.54-360.48%
TGTXTG Therapeutics Inc18.97-381.69%
MDXGMimedx Group Inc20.55-405.25%
XOMAXOMA Royalty Corp22.87-439.75%
ARGXArgen X SE24.30-460.89%
CTMXCytomX Therapeutics Inc24.82-468.66%
XOMAOXOMA Royalty Corp25.34-476.43%
HALOHalozyme Therapeutics Inc25.62-480.58%
XOMAPXOMA Royalty Corp25.67-481.27%
VRTXVertex Pharmaceuticals Inc27.99-515.79%
RPRXRoyalty Pharma plc - Class A28.69-526.08%
SLNOSoleno Therapeutics Inc29.02-530.95%
ASNDAscendis Pharma A/S30.09-546.85%
LGNDLigand Pharmaceuticals Inc - Class B37.91-663.09%
APLSApellis Pharmaceuticals Inc39.02-679.56%
BMRNBiomarin Pharmaceutical Inc42.21-726.95%
KRYSKrystal Biotech Inc45.34-773.47%
ONCBeiGene Ltd69.54-1132.85%
PHARPharming Group N.V.75.03-1214.32%
TECHBio-Techne Corp101.96-1614.34%
VCELVericel Corp109.92-1732.61%
ALNYAlnylam Pharmaceuticals Inc117.96-1852.08%
GMABGenmab140.29-2183.68%
TLXTelix Pharmaceuticals Ltd162.15-2508.38%
CORTCorcept Therapeutics Inc212.86-3261.48%